BAM
BHC icon

Brave Asset Management’s Bausch Health BHC Stock Holding History

Brave Asset Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,800
Closed -$221K – 152
2017
Q2 		$221K Buy
12,800
+2,000
+19% +$24K 0.12% 124
2017
Q1 		$119K Buy
+10,800
New +$149K 0.07% 138
2016
Q4 		– Sell
-1,000
Closed -$25K – 174
2016
Q3 		$25K Hold
1,000
– – 0.02% 269
2016
Q2 		$20K Hold
1,000
– – 0.01% 287
2016
Q1 		$26K Buy
+1,000
New +$74K 0.02% 273

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Brave Asset Management's BHC Position: Q3 2017 in Review

Brave Asset Management sold out of Bausch Health (BHC) in Q3 2017, closing a stake of 12,800 shares — an estimated $221K sold.

Brave Asset Management first reported a position in BHC in Q1 2016 and held it in 5 quarters. The position peaked at $221K in Q2 2017. 289 funds tracked by Wall St. Rank hold BHC as of Q3 2017.

  • Brave Asset Management reported no remaining Bausch Health position as of Q3 2017 after selling out during the quarter.
  • Brave Asset Management sold 12,800 Bausch Health shares in Q3 2017, an estimated $221K.
  • Brave Asset Management first reported a position in Bausch Health in Q1 2016 and held it in 5 quarters.
  • Brave Asset Management's Bausch Health position peaked at $221K in Q2 2017.
  • 289 funds tracked by Wall St. Rank held Bausch Health as of Q3 2017.

Based on Brave Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.